BCAX
Price
$20.00
Change
-$0.41 (-2.01%)
Updated
Jun 5 closing price
Capitalization
1.31B
72 days until earnings call
Intraday BUY SELL Signals
SION
Price
$35.37
Change
-$2.41 (-6.38%)
Updated
Jun 5 closing price
Capitalization
1.6B
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs SION

Header iconBCAX vs SION Comparison
Open Charts BCAX vs SIONBanner chart's image
BCAX vs SION Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCAX vs. SION commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and SION is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2026
Stock price -- (BCAX: $20.00 vs. SION: $35.37)
Brand notoriety: BCAX and SION are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 68% vs. SION: 110%
Market capitalization -- BCAX: $1.31B vs. SION: $1.6B
BCAX [@Biotechnology] is valued at $1.31B. SION’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.41B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileSION’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • SION’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than SION.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 4 TA indicator(s) are bullish while SION’s TA Score has 3 bullish TA indicator(s).

  • BCAX’s TA Score: 4 bullish, 6 bearish.
  • SION’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCAX is a better buy in the short-term than SION.

Price Growth

BCAX (@Biotechnology) experienced а -8.05% price change this week, while SION (@Biotechnology) price change was -17.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -7.98%, and the average quarterly price growth was -1.75%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

SION is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-7.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SION($1.6B) has a higher market cap than BCAX($1.31B). BCAX YTD gains are higher at: 18.835 vs. SION (-14.025). SION has higher annual earnings (EBITDA): -88.34M vs. BCAX (-141.04M). BCAX has more cash in the bank: 290M vs. SION (236M). BCAX has less debt than SION: BCAX (1.98M) vs SION (8.68M). BCAX (0) and SION (0) have equivalent revenues.
BCAXSIONBCAX / SION
Capitalization1.31B1.6B82%
EBITDA-141.04M-88.34M160%
Gain YTD18.835-14.025-134%
P/E Ratio3.41N/A-
Revenue00-
Total Cash290M236M123%
Total Debt1.98M8.68M23%
TECHNICAL ANALYSIS
Technical Analysis
BCAXSION
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
SION
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PMSE26.19-0.02
-0.10%
PGIM S&P 500 Max Buffer ETF - September
RMNY24.62-0.06
-0.24%
Rockefeller New York Municipal Bond ETF
IYC99.58-0.98
-0.98%
iShares US Consumer Discretionary ETF
INCO57.14-0.70
-1.20%
Columbia India Consumer ETF
SAMM32.17-1.52
-4.51%
Strategas Macro Momentum ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-2.01%
CLDX - BCAX
45%
Loosely correlated
-4.38%
PCVX - BCAX
45%
Loosely correlated
-2.87%
RCUS - BCAX
45%
Loosely correlated
-6.08%
BCYC - BCAX
43%
Loosely correlated
-1.64%
SION - BCAX
42%
Loosely correlated
-6.38%
More

SION and

Correlation & Price change

A.I.dvisor indicates that over the last year, SION has been loosely correlated with BCAX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SION jumps, then BCAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SION
1D Price
Change %
SION100%
-6.38%
BCAX - SION
42%
Loosely correlated
-2.01%
MGTX - SION
41%
Loosely correlated
-5.96%
NERV - SION
38%
Loosely correlated
+3.77%
PLRX - SION
37%
Loosely correlated
-1.71%
RCKT - SION
37%
Loosely correlated
-5.82%
More